ConvaTec Group PLC banner

ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 220 GBX 0.18% Market Closed
Market Cap: £4.3B

EBITDA Margin

25.5%
Current
Improving
by 1.7%
vs 3-y average of 23.9%

EBITDA Margin shows how much profit a company makes from its core operations before accounting for interest, taxes, and depreciation. It helps assess how efficiently the company runs its main business.

EBITDA Margin
25.5%
=
EBITDA
$623m
/
Revenue
$2.4B

EBITDA Margin shows how much profit a company makes from its core operations before accounting for interest, taxes, and depreciation. It helps assess how efficiently the company runs its main business.

EBITDA Margin
25.5%
=
EBITDA
GBX623m
/
Revenue
$2.4B

Peer Comparison

Country Company Market Cap EBITDA
Margin
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP
Loading...
JP
Hoya Corp
TSE:7741
9.3T JPY
Loading...
CH
Alcon AG
SIX:ALC
29.4B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.9B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
99.8B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.2B USD
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
931.6B JPY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.8B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
38.5B CNY
Loading...
CN
Intco Medical Technology Co Ltd
SZSE:300677
38B CNY
Loading...
US
Lantheus Holdings Inc
NASDAQ:LNTH
4.9B USD
Loading...

Market Distribution

Higher than 97% of companies in United Kingdom
Percentile
97th
Based on 3 605 companies
97th percentile
25.5%
Low
-182 253.3% — 0.1%
Typical Range
0.1% — 0.3%
High
0.3% — 6 324.9%
Distribution Statistics
United Kingdom
Min -182 253.3%
30th Percentile 0.1%
Median 0.2%
70th Percentile 0.3%
Max 6 324.9%

ConvaTec Group PLC
Glance View

Market Cap
4.3B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
LOCKED
Unlock
What is EBITDA Margin?
EBITDA Margin shows how much profit a company makes from its core operations before accounting for interest, taxes, and depreciation. It helps assess how efficiently the company runs its main business.
How is EBITDA Margin calculated?

EBITDA Margin is calculated by dividing the EBITDA by the Revenue.

EBITDA Margin
25.5%
=
EBITDA
$623m
/
Revenue
$2.4B
What is ConvaTec Group PLC's current EBITDA Margin?

The current EBITDA Margin for ConvaTec Group PLC is 25.5%, which is above its 3-year median of 23.9%.

How has EBITDA Margin changed over time?

Over the last 3 years, ConvaTec Group PLC’s EBITDA Margin has increased from 21.9% to 25.5%. During this period, it reached a low of 21.7% on Jun 30, 2023 and a high of 25.5% on Jan 1, 2026.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett